Dr Ryan Cawood
Founder & Chief Executive Officer
Ryan founded Oxford Genetics in 2011 with the aim to revolutionize DNA design, optimisation and assembly to enable molecular engineering to fulfil its promise in synthetic biology and medicine.
Chief Operating Officer
Jocelyne has an extensive background working in businesses from science and engineering technology sectors. Prior to joining Oxford Genetics she was Chief Revenue Officer at EYOTO, where she determined product strategy and was responsible for a complete rebrand of the organisation as well as building a sales and marketing team.
Chief Financial Officer
Martin joined Oxford Genetics in November 2017 and has more than 30 years financial and general management experience in technology and IP-focused businesses.
Dr Tom Payne
Chief Scientific Officer
Tom has more than 15 years commercial experience in biopharmaceutical development and bioproduction. He has previously held R&D and commercially-focused roles at both Novozymes Biopharma (now Albumedix) and Lonza in the UK.